PATENT CLAIM ANALYSIS

Application Number: 16307841
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "021100"]

Abstract:
Provided are backbone cyclized peptides that interfere with signaling of the intracellular adaptor protein MyD88. Pharmaceutical compositions including these backbone cyclized peptides as well as their use in treatment of multiple sclerosis (MS) and other diseases associated with MyD88 signaling are also disclosed.

Claim (Index 19):
A backbone cyclic peptide having a structure according to Formula III: wherein m and n are each independently an integer of 2, 3, 4 or 6; B is selected from the group consisting of: 0, S and NH; Z is selected from the group consisting of: hydrogen, Trp residue, and permeability enhancing moiety; and BU designates a N \u03b1 -\u03c9-functionalized amino acid residue.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.27027
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14581752', '15703457', '14482946', '13761277', '14354608']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7674089561399486
- 35 USC 102 Novelty (BERT): 0.5071393290225986
- Combined Prediction Score: 0.7413819934282136
- Mean Citation Score: 233.179912
- Max Citation Score: 241.90733
- Similarity Product: 167.61546987780213

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test